Back to top
more

Quest Diagnostics (DGX)

(Delayed Data from NYSE)

$195.00 USD

195.00
1,292,236

-2.76 (-1.40%)

Updated Jun 18, 2026 04:01 PM ET

After-Market: $194.93 -0.07 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (85 out of 247)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Quest Diagnostics (DGX) is a Top-Ranked Growth Stock: Should You Buy?

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Here's Why You Should Add NVST Stock to Your Portfolio Right Now

by Zacks Equity Research

Envista's global expansion, bolt-on acquisitions, and strong balance sheet support growth, even as currency swings pressure sales.

Zacks Equity Research

IDEXX Stock Up 64.7% in a Year: What's Driving the Growth?

by Zacks Equity Research

IDXX shares surge 64.7% in a year as CAG Diagnostics momentum, strong retention and expanding software adoption fuel growth across regions.

Moumi Mondal headshot

Hologic's Breast Health Unit Stays In Focus in 2026: What Lies Ahead?

by Moumi Mondal

HOLX's Breast Health unit is back in focus as a proposed Blackstone-TPG deal adds a $76 cash offer and CVR to 2026-27 revenue goals.

Zacks Equity Research

Should Labcorp Stock Stay in Your Portfolio Right Now?

by Zacks Equity Research

LH's growth bets in specialty testing and acquisitions support its outlook, but macro pressures and currency headwinds remain key risks.

Zacks Equity Research

Is it the Right Time to Add Insulet Stock to Your Portfolio?

by Zacks Equity Research

PODD gains momentum as Omnipod 5 adoption accelerates, margins scale, and earnings estimates rise despite macro and concentration risks.

Zacks Equity Research

Quest Diagnostics (DGX) Upgraded to Buy: Here's Why

by Zacks Equity Research

Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now?

by Zacks Equity Research

DGX banks on acquisitions, advanced diagnostics and cost discipline, even as debt levels and macro pressures pose risks.

Zacks Equity Research

Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Quest Diagnostics (DGX) and Elicio Therapeutics (ELTX) have performed compared to their sector so far this year.

Zacks Equity Research

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.